28098510|t|DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS
28098510|a|We combined double inversion recovery (DIR) and diffusion tensor (DT) magnetic resonance imaging (MRI) to quantify the severity of cortical lesion (CL) microstructural tissue abnormalities in a large cohort of relapse - onset multiple sclerosis (MS) patients and its contribution to cognitive dysfunction. DIR, DT, dual-echo, and three-dimensional (3D) T1-weighted scans were acquired from 149 MS patients and 40 controls. Cognitively impaired (CI) patients had â©¾2 abnormal neuropsychological tests. Diffusivity values in CLs, cortex, white matter (WM) lesions, and normal-appearing (NA) WM were assessed. Predictors of cognitive impairment were identified using a random forest analysis. Compared to controls, MS patients had lower normalized brain volume (NBV), gray matter volume (GMV), WM volume, lower fractional anisotropy (FA), and higher mean diffusivity in cortex and normal-appearing white matter (NAWM). A total of 44 (29.5%) patients were CI. Compared to cognitively preserved (CP), CI patients had higher T2 WM lesion volume (LV), lower NBV and GMV, and more severe diffusivity abnormalities in WM lesions, cortex, and NAWM. CL measures did not differ between CI and CP patients. Cortex FA, age, disease duration, T2 WM LV, and GMV best predicted MS -related cognitive impairment (C-statistic = 0.88). " Diffuse " GM and NAWM damage and WM lesions, rather than intrinsic CL damage, contribute to cognitive impairment in MS.
28098510	0	6	DT MRI	T060	C3163713
28098510	7	22	microstructural	T080	C0205556
28098510	23	31	cortical	T023	C0007776
28098510	32	38	lesion	T047	C0221505
28098510	39	45	damage	T169	C1883709
28098510	63	83	cognitive impairment	T048	C0338656
28098510	87	89	MS	T047	C0026769
28098510	102	127	double inversion recovery	T060	C0430022
28098510	129	132	DIR	T060	C0430022
28098510	138	192	diffusion tensor (DT) magnetic resonance imaging (MRI)	T060	C3163713
28098510	196	204	quantify	T081	C1709793
28098510	209	217	severity	T080	C0439793
28098510	221	229	cortical	T023	C0007776
28098510	230	236	lesion	T047	C0221505
28098510	238	240	CL	T047	C0221505
28098510	242	257	microstructural	T080	C0205556
28098510	258	264	tissue	T024	C0040300
28098510	265	278	abnormalities	T020	C0221430
28098510	284	289	large	T081	C0549177
28098510	290	296	cohort	T098	C0599755
28098510	300	307	relapse	T067	C0035020
28098510	310	315	onset	T080	C0332162
28098510	316	334	multiple sclerosis	T047	C0026769
28098510	336	338	MS	T047	C0026769
28098510	340	348	patients	T101	C0030705
28098510	357	369	contribution	T052	C1880177
28098510	373	394	cognitive dysfunction	T048	C0338656
28098510	396	399	DIR	T060	C0430022
28098510	401	403	DT	T060	C1537007
28098510	405	414	dual-echo	T060	C0011923
28098510	420	437	three-dimensional	T082	C0450363
28098510	439	441	3D	T082	C0450363
28098510	443	460	T1-weighted scans	T060	C0011923
28098510	484	486	MS	T047	C0026769
28098510	487	495	patients	T101	C0030705
28098510	503	511	controls	T096	C0009932
28098510	513	533	Cognitively impaired	T048	C0338656
28098510	535	537	CI	T048	C0338656
28098510	539	547	patients	T101	C0030705
28098510	555	563	abnormal	T033	C0205161
28098510	564	588	neuropsychological tests	T060	C0027902
28098510	590	608	Diffusivity values	T077	C3899378
28098510	612	615	CLs	T047	C0221505
28098510	617	623	cortex	T023	C0007776
28098510	625	650	white matter (WM) lesions	T033	C2752009
28098510	656	680	normal-appearing (NA) WM	T024	C0682708
28098510	686	694	assessed	T052	C1516048
28098510	696	706	Predictors	T078	C2698872
28098510	710	730	cognitive impairment	T048	C0338656
28098510	736	746	identified	T080	C0205396
28098510	755	777	random forest analysis	T062	C0936012
28098510	791	799	controls	T096	C0009932
28098510	801	803	MS	T047	C0026769
28098510	804	812	patients	T101	C0030705
28098510	817	822	lower	T080	C0205251
28098510	823	846	normalized brain volume	T081	C1113695
28098510	848	851	NBV	T081	C1113695
28098510	854	872	gray matter volume	T081	C0392762
28098510	874	877	GMV	T081	C0392762
28098510	880	889	WM volume	T033	C3278845
28098510	891	896	lower	T080	C0205251
28098510	897	918	fractional anisotropy	T081	C0392762
28098510	920	922	FA	T081	C0392762
28098510	929	935	higher	T080	C0205250
28098510	936	952	mean diffusivity	T077	C3899378
28098510	956	962	cortex	T023	C0007776
28098510	967	996	normal-appearing white matter	T024	C0682708
28098510	998	1002	NAWM	T024	C0682708
28098510	1027	1035	patients	T101	C0030705
28098510	1041	1043	CI	T048	C0338656
28098510	1057	1078	cognitively preserved	T101	C0030705
28098510	1080	1082	CP	T101	C0030705
28098510	1085	1087	CI	T048	C0338656
28098510	1088	1096	patients	T101	C0030705
28098510	1101	1107	higher	T080	C0205250
28098510	1108	1127	T2 WM lesion volume	T081	C0392762
28098510	1129	1131	LV	T081	C0392762
28098510	1134	1139	lower	T080	C0205251
28098510	1140	1143	NBV	T081	C1113695
28098510	1148	1151	GMV	T081	C0392762
28098510	1162	1168	severe	T080	C0205082
28098510	1169	1180	diffusivity	T077	C3899378
28098510	1181	1194	abnormalities	T020	C0221430
28098510	1198	1208	WM lesions	T033	C2752009
28098510	1210	1216	cortex	T023	C0007776
28098510	1222	1226	NAWM	T024	C0682708
28098510	1228	1230	CL	T047	C0221505
28098510	1231	1239	measures	T081	C0079809
28098510	1244	1254	not differ	T033	C0243095
28098510	1263	1265	CI	T101	C0030705
28098510	1270	1281	CP patients	T101	C0030705
28098510	1283	1289	Cortex	T023	C0007776
28098510	1290	1292	FA	T081	C0392762
28098510	1294	1297	age	T032	C0001779
28098510	1299	1315	disease duration	T079	C0872146
28098510	1317	1325	T2 WM LV	T081	C0392762
28098510	1331	1334	GMV	T081	C0392762
28098510	1350	1352	MS	T047	C0026769
28098510	1362	1382	cognitive impairment	T048	C0338656
28098510	1407	1414	Diffuse	T082	C0205219
28098510	1417	1419	GM	T024	C0018220
28098510	1424	1428	NAWM	T024	C0682708
28098510	1429	1435	damage	T169	C1883709
28098510	1440	1450	WM lesions	T033	C2752009
28098510	1464	1473	intrinsic	T082	C0205102
28098510	1474	1476	CL	T047	C0221505
28098510	1477	1483	damage	T169	C1883709
28098510	1499	1519	cognitive impairment	T048	C0338656
28098510	1523	1525	MS	T047	C0026769